Dernières nouvelles
Information non disponible
Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium
Article de revueMol Cytogenet, 17 (1), 2024.
Use of cell-free signals as biomarkers for early and easy prediction of preeclampsia
Article de revueFront Med (Lausanne), 10 , 2023.
Patient attitudes and preferences about expanded noninvasive prenatal testing
Article de revueFront Genet, 14 , 2023.
Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes
Article de revueFront Genet, 13 , 2022.
A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study
Article de revueCancers (Basel), 13 (11), 2021.
Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study
Article de revueEur J Hum Genet, 27 (11), 2019.
Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis
Article de revueJ Obstet Gynaecol Can, 40 (1), 2018.
Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome
Article de revueEur J Hum Genet, 25 (4), 2017.
Comparison of first-tier cell-free DNA screening for common aneuploidies with conventional publically funded screening
Article de revuePrenat Diagn, 37 (12), 2017.
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues
Article de revueAppl Clin Genet, 9 , 2016.